|
시장보고서
상품코드
2152370
무균 샘플링 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 방법별, 용도별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)Aseptic Sampling Market Size, Share & Trends Analysis Report By Type (Manual Aseptic Sampling), By Technique, By Application (Downstream Processing, Upstream Processing), By End-use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
무균 샘플링 시장 요약
세계의 무균 샘플링 시장 규모는 2025년에 11억 달러로 평가되며, 2026년 12억 달러에서 2033년까지 20억 달러로 성장할 것으로 예상되며, 2026-2033년의 연평균 성장률(CAGR)은 8.0%에 달할 것으로 전망됩니다.
북미가 시장을 주도하고 있으며, 2025년에는 38.5%라는 가장 큰 매출 점유율을 차지했습니다. 세계 인구 증가, 맞춤형 의료에 대한 수요 증가, 그리고 기술 개발의 진전이 무균 샘플링 시장의 성장을 지원할 것으로 예상됩니다.
자주 묻는 질문
목차
제1장 조사 방법 및 범위
제2장 요약
제3장 시장: 변수, 동향, 범위
- 시장 계보 전망
- 시장 역학
- 업계 분석 툴
제4장 유형별 비즈니스 분석
- 무균 샘플링 시장: 유형별 동향 분석
- 수동 무균 샘플링
- 자동화된 무균 샘플링
제5장 기법별 비즈니스 분석
- 무균 샘플링 시장: 기법별 동향 분석
- 인라인 샘플링 기법
- 온라인 샘플링 기법
- 오프라인 샘플링 기법
제6장 용도별 비즈니스 분석
- 무균 샘플링 시장: 용도별 동향 분석
- 하류 공정
- 상류 공정
제7장 최종 용도별 비즈니스 분석
- 무균 샘플링 시장: 최종 용도별 동향 분석
- 제약·바이오기술 기업
- CMO 및 CRO
- 기타
제8장 지역별 비즈니스 분석
- 무균 샘플링 시장 점유율: 지역별, 2025-2033년
- 북미
- 북미 무균 샘플링 시장, 2021년?2033년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽 무균 샘플링 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양 무균 샘플링 시장, 2021년?2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 라틴아메리카
- 라틴아메리카의 무균 샘플링 시장, 2021년?2033년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- MEA 무균 샘플링 시장, 2021-2033년
- 남아프리카
- 사우디아라비아
- UAE
- 쿠웨이트
제9장 경쟁 현황
- 기업 분류
- 기업 점유율 및 포지셔닝 분석, 2025년
- 전략 매핑
- 기업 개요 및 리스트
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Sartorius AG
- Eppendorf SE
- Lonza
- GEA Group
- KEOFITT A/S
- Qualitru Sampling Systems
- W. L. Gore & Associates, Inc.
Aseptic Sampling Market Summary
The global aseptic sampling market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, at a CAGR of 8.0% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 38.5% in 2025. Growing population across the globe, the rising demand for personalized medicines, and the growing technological development are anticipated to boost the market growth of aseptic sampling.
Global Aseptic Sampling Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global aseptic sampling market report based on type, technique, application, end use, and region
- Type Outlook (Revenue, USD Billion, 2021 - 2033)
- Manual Aseptic Sampling
- Valve
- Bags
- Bottle
- Other Accessories
- Automated Aseptic Sampling
- Technique Outlook (Revenue, USD Billion, 2021 - 2033)
- In-line Sampling Technique
- On-line Sampling Technique
- Off-line Sampling Technique
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Downstream Processing
- Upstream Processing
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- CMOs & CROs
- Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Type Segment
- 1.1.1.2. Technique Segment
- 1.1.1.3. Application Segment
- 1.1.1.4. End Use Segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Adoption of Single-Use Bioprocessing Systems
- 3.2.1.2. Rising Biopharmaceutical Production and Manufacturing
- 3.2.1.3. Growing Focus on Contamination Control and Sterility Assurance
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Risk of Sampling Errors and Contamination
- 3.2.2.2. High Cost of Advanced Aseptic Sampling Systems
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
- 3.3.1. Porter's Five Forces Analysis
Chapter 4. Type Business Analysis
- 4.1. Segment Dashboard
- 4.2. Aseptic Sampling Market: Type Movement Analysis
- 4.3. Manual Aseptic Sampling
- 4.3.1. Manual Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 4.3.2. Valve
- 4.3.2.1. Valve Market, 2021 - 2033 (USD Billion)
- 4.3.3. Bags
- 4.3.3.1. Bags Market, 2021 - 2033 (USD Billion)
- 4.3.4. Bottle
- 4.3.4.1. Bottle Market, 2021 - 2033 (USD Billion)
- 4.3.5. Other Accessories
- 4.3.5.1. Other Accessories Market, 2021 - 2033 (USD Billion)
- 4.4. Automated Aseptic Sampling
- 4.4.1. Automated Aseptic Sampling Market, 2021 - 2033 (USD Billion)
Chapter 5. Technique Business Analysis
- 5.1. Segment Dashboard
- 5.2. Aseptic Sampling Market: Technique Movement Analysis
- 5.3. In-line Sampling Technique
- 5.3.1. In-line Sampling Technique Market, 2021 - 2033 (USD Billion)
- 5.4. On-line Sampling Technique
- 5.4.1. On-line Sampling Technique Market, 2021 - 2033 (USD Billion)
- 5.5. Off-line Sampling Technique
- 5.5.1. Off-line Sampling Technique Market, 2021 - 2033 (USD Billion)
Chapter 6. Application Business Analysis
- 6.1. Segment Dashboard
- 6.2. Aseptic Sampling Market: Application Movement Analysis
- 6.3. Downstream Processing
- 6.3.1. Downstream Processing Market, 2021 - 2033 (USD Billion)
- 6.4. Upstream Processing
- 6.4.1. Upstream Processing Market, 2021 - 2033 (USD Billion)
Chapter 7. End Use Business Analysis
- 7.1. Segment Dashboard
- 7.2. Aseptic Sampling Market: End Use Movement Analysis
- 7.3. Pharmaceutical & Biotechnology Companies
- 7.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Billion)
- 7.4. CMOs & CROs
- 7.4.1. CMOs & CROs Market, 2021 - 2033 (USD Billion)
- 7.5. Others
- 7.5.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 8. Regional Business Analysis
- 8.1. Aseptic Sampling Market Share By Region, 2025 & 2033
- 8.2. North America
- 8.2.1. North America Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.2.2. U.S.
- 8.2.2.1. Key Country Dynamics
- 8.2.2.2. Competitive Scenario
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. U.S. Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.2.3. Canada
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Canada Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.2.4. Mexico
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Mexico Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3.2. UK
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. UK Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3.3. Germany
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Germany Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3.4. France
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. France Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3.5. Italy
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Italy Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3.6. Spain
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Spain Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3.7. Denmark
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Denmark Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3.8. Sweden
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Sweden Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.3.9. Norway
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Norway Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Japan Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. China Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. India Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.4.5. Australia
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Australia Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.4.6. Thailand
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Thailand Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.4.7. South Korea
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. South Korea Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Brazil Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.5.3. Argentina
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Argentina Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.6. MEA
- 8.6.1. MEA Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. South Africa Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Saudi Arabia Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. UAE Aseptic Sampling Market, 2021 - 2033 (USD Billion)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Kuwait Aseptic Sampling Market, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Company Market Share/ Position Analysis, 2025
- 9.3. Strategy Mapping
- 9.4. Company Profiles/Listing
- 9.4.1. Danaher Corporation
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Thermo Fisher Scientific Inc.
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Merck KGaA
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Sartorius AG
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Eppendorf SE
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Lonza
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. GEA Group
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. KEOFITT A/S
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Qualitru Sampling Systems
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. W. L. Gore & Associates, Inc.
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives
- 9.4.1. Danaher Corporation
